Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two anonymous men share their experiences being newly diagnosed.
Plus: An interview with the documentary’s director, Daniel F. Cardone
For those with advanced liver disease, treatment for hepatitis C is more complex. But the new treatments offer considerable hope as well.
Why LGBT people, sex workers and injection drug users must be part of the discussion on ending AIDS.
POZ talks with the legendary singer about what drives her fervent activism and why she can’t stop shouting.
June 6 webinars offering technical assistance for applicants seeking funding for programs for HIV/HCV coinfected people of color
The manager of pop singer Sia chats with POZ contributing writer Shawn Decker.
Probuphine promises to deliver six months of continuous buprenorphine treatment. What does this mean for the future of the opioid epidemic?
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
The big news from the recent European liver conference.
New research suggests that the United States’ dismally low rate of viral suppression may have been quite the underestimate.
Research suggests that some people are taking hep C therapy for longer periods than they actually need.
The White House, in collaboration with HHS, announces a Summit to highlight initiatives to shorten the time to receive life-saving organs.
A primer on the harms of HIV-related chronic inflammation, what treatments are being researched and what you can do to reduce inflammation.
A report finds that the provisions of the Affordable Care Act have resulted in an estimated 20 million people gaining health insurance
Over 100 grassroots advocates participated in Hepatitis on the Hill to increase the urgency and national response to viral hepatitis